Area of research
Oncology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Antibody, Trastuzumab, Chemistry, Pharmacology, Monoclonal antibody, and Cancer.
Utilizing PK and PD Biomarkers to Guide the First-in-Human Starting Dose Selection of MTBT1466A: A Novel Humanized Monoclonal Anti-TGFβ3 Antibody for the Treatment of Fibrotic Diseases
Trastuzumab does not bind rat or mouse ErbB2/neu: implications for selection of non-clinical safety models for trastuzumab-based therapeutics
Personalized Cancer Vaccines: Clinical Landscape, Challenges, and Opportunities
Anti–Lymphocyte Antigen 6 Complex, Locus E-Seco-Cyclopropabenzindol-4-One-Dimer Antibody-Drug Conjugate That Forms Adduct with α1-Microglobulin Demonstrates Slower Systemic Antibody Clearance and Reduced Tumor Distribution in Animals
Non-Clinical Disposition and Metabolism of DM1, a Component of Trastuzumab Emtansine (T-DM1), in Sprague Dawley Rats
Potential Mechanisms for Thrombocytopenia Development with Trastuzumab Emtansine (T-DM1)